The purpose of this study is to determine whether tracing data (maternal and fetal heart rate) collected remotely on the Nuvo Invu device can be used for clinical management of pregnant patients. We will be recruiting generally healthy pregnant women with singleton gestations who at at least 32 weeks gestation and have a clinical indication for fetal monitoring. Subjects will be given the Invu device to use at home and will be asked to perform at least two, but up to 20 (2x per week for up to 10 weeks) remote monitoring sessions. The data collected by the device is transmitted wirelessly to a provider platform on which the tracing can be viewed. Existing patients within the Penn Medicine Health System will be recruited for this study.

You may be eligible for this study if you meet the following criteria:

• Conditions: pregnancy
• Age: 99 years or below
• Gender: All